Community Health Systems Inc (CYH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $315.90M
Last updated: Nov 17, 2026 at 11:03 AM ET
Community Health Systems Inc (CYH) Financials: Revenue, Profit and Cash Flow
Community Health Systems reported revenue of $12.48B for the fiscal year ended Dec 31, 2025, down 1.2% from the year before. That year, net income was $676.00M with a net margin of 5.4%, operating cash flow was $543.00M and free cash flow was $208.00M. The quarter ended Sep 30, 2026 had revenue of $2.76B and net income of -$50.00M.
Revenue and Margins
The operating margin was 11.9% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue fell from $18.44B, a compound annual decline of 4.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $12.48B | -1.2% | 41.7% | 11.9% | 5.4% |
| Dec 2024 | $12.63B | +1.2% | 41.7% | 4.3% | -2.9% |
| Dec 2023 | $12.49B | +2.3% | 40.7% | 7.7% | 0.1% |
| Dec 2022 | $12.21B | -1.3% | 37.6% | 6.7% | 1.5% |
| Dec 2021 | $12.37B | -0.2% | 41.1% | 11.3% | 3.0% |
| Dec 2020 | $12.39B | -6.2% | 37.8% | 9.1% | 4.9% |
| Dec 2019 | $13.21B | -6.7% | 38.7% | 4.9% | -4.5% |
| Dec 2018 | $14.15B | -7.8% | 38.3% | 1.5% | -5.0% |
| Dec 2017 | $15.35B | -16.7% | 34.6% | -12.2% | -15.6% |
| Dec 2016 | $18.44B | N/A | 36.9% | -4.7% | -8.8% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $12.39B | $13.21B | $14.15B | $15.35B | $18.44B |
| Cost of revenue | $7.28B | $7.36B | $7.41B | $7.62B | $7.28B | $7.70B | $8.10B | $8.74B | $10.05B | $11.63B |
| Gross profit | $5.21B | $5.27B | $5.08B | $4.59B | $5.08B | $4.69B | $5.11B | $5.42B | $5.30B | $6.80B |
| Operating income | $1.49B | $542.00M | $957.00M | $821.00M | $1.40B | $1.13B | $650.00M | $208.00M | -$1.88B | -$860.00M |
| Net income | $676.00M | -$362.00M | $16.00M | $179.00M | $368.00M | $607.00M | -$590.00M | -$704.00M | -$2.40B | -$1.63B |
| EBITDA | $1.91B | $1.03B | $1.46B | $1.47B | $1.94B | $1.68B | $1.26B | $908.00M | -$1.02B | $240.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B |
| Gross profit | $1.14B | $1.19B | $1.20B | $1.30B | $1.27B | $1.34B | $1.30B | $1.40B | $1.26B | $1.33B | $1.28B | $1.40B |
| Operating income | $146.00M | $389.00M | $281.00M | $449.00M | $243.00M | $512.00M | $284.00M | $278.00M | -$205.00M | $238.00M | $231.00M | $328.00M |
| Net income | -$50.00M | $104.00M | -$25.00M | $160.00M | $171.00M | $320.00M | $25.00M | -$27.00M | -$355.00M | $26.00M | -$6.00M | $86.00M |
Balance Sheet
As of Dec 2025, total debt of $10.40B exceeded cash and equivalents by $10.14B. Shareholder equity was negative, at -$1.39B, as total liabilities of $14.04B exceeded total assets of $13.20B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B |
| Current assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B |
| Cash and equivalents | $260.00M | $37.00M | $38.00M | $118.00M | $507.00M | $1.68B | $216.00M | $196.00M | $563.00M | $238.00M |
| Total liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B |
| Short-term debt | $16.00M | $20.00M | $21.00M | $21.00M | $31.00M | $123.00M | $20.00M | $204.00M | $33.00M | $455.00M |
| Long-term debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | $13.39B | $13.88B | $14.79B |
| Shareholder equity | -$1.39B | -$1.91B | -$1.39B | -$1.37B | -$1.37B | -$1.63B | -$2.22B | -$1.53B | -$767.00M | $1.61B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.11B | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | $14.46B |
| Total liabilities | $13.04B | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | $15.28B |
| Cash and equivalents | $155.00M | $149.00M | $712.00M | $260.00M | $123.00M | $456.00M | $431.00M | $37.00M | $33.00M | $39.00M | $48.00M | $38.00M |
| Shareholder equity | -$1.49B | -$1.39B | -$1.45B | -$1.39B | -$1.50B | -$1.63B | -$1.92B | -$1.91B | -$1.82B | -$1.44B | -$1.43B | -$1.39B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 38.3% of operating cash flow. Dividends came to 80.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $543.00M | $480.00M | $210.00M | $300.00M | -$131.00M | $2.18B | $385.00M | $274.00M | $773.00M | $1.14B |
| Capital expenditures | $335.00M | $360.00M | $467.00M | $415.00M | $469.00M | $440.00M | $438.00M | $527.00M | $564.00M | $744.00M |
| Free cash flow | $208.00M | $120.00M | -$257.00M | -$115.00M | -$600.00M | $1.74B | -$53.00M | -$253.00M | $209.00M | $393.00M |
| Dividends paid | $167.00M | $158.00M | $142.00M | $130.00M | $140.00M | $117.00M | $110.00M | $127.00M | $106.00M | $111.00M |
| Investing cash flow | $847.00M | -$275.00M | -$26.00M | -$259.00M | -$524.00M | $177.00M | -$2.00M | -$245.00M | $1.07B | $630.00M |
| Financing cash flow | -$1.17B | -$206.00M | -$264.00M | -$430.00M | -$514.00M | -$895.00M | -$363.00M | -$396.00M | -$1.52B | -$1.71B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $154.00M | $88.00M | -$297.00M | $266.00M | $69.00M | $88.00M | $120.00M | $216.00M | $67.00M | $101.00M | $96.00M | $90.00M |
| Capital expenditures | $87.00M | $76.00M | $76.00M | $94.00M | $65.00M | $91.00M | $85.00M | $109.00M | $70.00M | $88.00M | $93.00M | $110.00M |
| Free cash flow | $67.00M | $12.00M | -$373.00M | $172.00M | $4.00M | -$3.00M | $35.00M | $107.00M | -$3.00M | $13.00M | $3.00M | -$20.00M |
Frequently Asked Questions About CYH
What is Community Health Systems' annual revenue?
Community Health Systems reported revenue of $12.48B for the fiscal year ended Dec 31, 2025.
How fast is Community Health Systems' revenue growing?
Revenue was down 1.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.7%.
Is Community Health Systems profitable?
Yes. Community Health Systems reported net income of $676.00M for the fiscal year ended Dec 31, 2025, with a net margin of 5.4%.
How much free cash flow does CYH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $543.00M minus capital expenditures of $335.00M produced free cash flow of $208.00M.
How much debt does Community Health Systems have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $10.38B, short-term debt of $16.00M and cash and equivalents of $260.00M.
CYH pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts